Medication review with follow-up for cardiovascular outcomes: a trial based cost-utility analysis.
作者： Shalom Benrimoj , Carlos Balmaceda , José Cristian Plaza-Plaza , Constanza Vargas , Victoria Garcia-Cardenas
关键词:
摘要: Aim: To assess the trial-based cost-effectiveness of medication review with follow-up compared usual care in primary care. Materials & methods: A cluster randomized controlled trial included patients if they were independent older adults, receiving five or more prescriptions, moderate or high cardiovascular risk. Costs estimated from public healthcare sector perspective, and health benefits measured as quality-adjusted life years. Both which used to calculate incremental ratio. Results: Twelve centers completed study, six (146 patients) intervention group (145 control group. The base-case analysis showed an ratio of US$ (2019) 434.4/quality-adjusted year (95% CI 64.20-996.03). Conclusion: was cost-effective setting.
sci-hub.st 参考文章(37)
The Measurement of Interrater Agreement John Wiley & Sons, Inc.. pp. 598- 626 ,(2004) , 10.1002/0471445428.CH18
Carla Castrillon Ocampo, Victoria Garcia-Cardenas, Fernando Martinez-Martinez, Shalom I. Benrimoj, Pedro Amariles, Miguel Angel Gastelurrutia, Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes International Journal of Clinical Pharmacy. ,vol. 37, pp. 931- 940 ,(2015) , 10.1007/S11096-015-0145-9
Handbook of multilevel analysis Springer. ,(2008) , 10.1007/978-0-387-73186-5
Gloria lcaza, Loreto Núñez, Jaume Marrugat, Verónica Mujica, M. Cristina Escobar, Ana Luisa Jiménez, Paulina Pérez, Iván Palomo, Estimación de riesgo de enfermedad coronaria mediante la función de Framingham adaptada para la población chilena Revista Medica De Chile. ,vol. 137, pp. 1273- 1282 ,(2009) , 10.4067/S0034-98872009001000001
Terri R. Fried, John O'Leary, Virginia Towle, Mary K. Goldstein, Mark Trentalange, Deanna K. Martin, Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review Journal of the American Geriatrics Society. ,vol. 62, pp. 2261- 2272 ,(2014) , 10.1111/JGS.13153
Camilo Cid P, Gabriel Bastías S, Evaluando la situación financiera de los hospitales públicos a partir de los costos actualizados de sus prestaciones Revista Medica De Chile. ,vol. 142, pp. 161- 167 ,(2014) , 10.4067/S0034-98872014000200003
Maxwell O Adibe, Cletus N Aguwa, Chinwe V Ukwe, None, Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes Value in health regional issues. ,vol. 2, pp. 189- 198 ,(2013) , 10.1016/J.VHRI.2013.06.009
Alain Desgagné, Anne-Marie Castilloux, Jean-François Angers, Jacques Le Lorier, The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. PharmacoEconomics. ,vol. 13, pp. 487- 497 ,(1998) , 10.2165/00019053-199813050-00002
Victor Zarate, Paul Kind, Paulina Valenzuela, Alberto Vignau, Pedro Olivares-Tirado, Alberto Munoz, Social Valuation of EQ-5D Health States: The Chilean Case Value in Health. ,vol. 14, pp. 1135- 1141 ,(2011) , 10.1016/J.JVAL.2011.09.002
Andrew Briggs, Paul Fenn, Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Economics. ,vol. 7, pp. 723- 740 ,(1998) , 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.0.CO;2-O